Home/ Stocks/ DGX

Quest Diagnostics Inc.

DGX XNYS

$238.73 -1.57 (-0.65%) ▼ 15-min delayed

Open

$242.72

High

$243.72

Low

$238.06

Volume

230.6K

Market Cap

$26.52B

About Quest Diagnostics Inc.

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Sector: SERVICES-MEDICAL LABORATORIES Employees: 57.0K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$3.04B	$334.00M	$2.88
Q1 2026	$2.90B	$264.00M	$2.27
FY 2025	$11.04B	$1.05B	$8.87
Q3 2025	$2.82B	$259.00M	$2.18

TickerDaily Coverage

Why Is bioAffinity Technologies, Inc. Common Stock (BIAF) Stock Up 59.2% Today?

Market News Alex Chen · 2h ago

bioAffinity Technologies (BIAF) stock exploded 59.2% higher Tuesday, September 1, 2026, reaching...

View All Coverage →

Get DGX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Quest Diagnostics Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.